Everything real about unreal artificial intelligence in diabetic retinopathy and in ocular pathologies

Artificial Intelligence is a multidisciplinary field with the aim of building platforms that can make machines act, perceive, reason intelligently and whose goal is to automate activities that presently require human intelligence. From the cornea to the retina, artificial intelligence (AI) is expect...

Descripción completa

Detalles Bibliográficos
Autores principales: Morya, Arvind Kumar, Janti, Siddharam S, Sisodiya, Priya, Tejaswini, Antervedi, Prasad, Rajendra, Mali, Kalpana R, Gurnani, Bharat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606792/
https://www.ncbi.nlm.nih.gov/pubmed/36311999
http://dx.doi.org/10.4239/wjd.v13.i10.822
_version_ 1784818377627271168
author Morya, Arvind Kumar
Janti, Siddharam S
Sisodiya, Priya
Tejaswini, Antervedi
Prasad, Rajendra
Mali, Kalpana R
Gurnani, Bharat
author_facet Morya, Arvind Kumar
Janti, Siddharam S
Sisodiya, Priya
Tejaswini, Antervedi
Prasad, Rajendra
Mali, Kalpana R
Gurnani, Bharat
author_sort Morya, Arvind Kumar
collection PubMed
description Artificial Intelligence is a multidisciplinary field with the aim of building platforms that can make machines act, perceive, reason intelligently and whose goal is to automate activities that presently require human intelligence. From the cornea to the retina, artificial intelligence (AI) is expected to help ophthalmologists diagnose and treat ocular diseases. In ophthalmology, computerized analytics are being viewed as efficient and more objective ways to interpret the series of images and come to a conclusion. AI can be used to diagnose and grade diabetic retinopathy, glaucoma, age-related macular degeneration, cataracts, IOL power calculation, retinopathy of prematurity and keratoconus. This review article intends to discuss various aspects of artificial intelligence in ophthalmology.
format Online
Article
Text
id pubmed-9606792
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-96067922022-10-28 Everything real about unreal artificial intelligence in diabetic retinopathy and in ocular pathologies Morya, Arvind Kumar Janti, Siddharam S Sisodiya, Priya Tejaswini, Antervedi Prasad, Rajendra Mali, Kalpana R Gurnani, Bharat World J Diabetes Review Artificial Intelligence is a multidisciplinary field with the aim of building platforms that can make machines act, perceive, reason intelligently and whose goal is to automate activities that presently require human intelligence. From the cornea to the retina, artificial intelligence (AI) is expected to help ophthalmologists diagnose and treat ocular diseases. In ophthalmology, computerized analytics are being viewed as efficient and more objective ways to interpret the series of images and come to a conclusion. AI can be used to diagnose and grade diabetic retinopathy, glaucoma, age-related macular degeneration, cataracts, IOL power calculation, retinopathy of prematurity and keratoconus. This review article intends to discuss various aspects of artificial intelligence in ophthalmology. Baishideng Publishing Group Inc 2022-10-15 2022-10-15 /pmc/articles/PMC9606792/ /pubmed/36311999 http://dx.doi.org/10.4239/wjd.v13.i10.822 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Review
Morya, Arvind Kumar
Janti, Siddharam S
Sisodiya, Priya
Tejaswini, Antervedi
Prasad, Rajendra
Mali, Kalpana R
Gurnani, Bharat
Everything real about unreal artificial intelligence in diabetic retinopathy and in ocular pathologies
title Everything real about unreal artificial intelligence in diabetic retinopathy and in ocular pathologies
title_full Everything real about unreal artificial intelligence in diabetic retinopathy and in ocular pathologies
title_fullStr Everything real about unreal artificial intelligence in diabetic retinopathy and in ocular pathologies
title_full_unstemmed Everything real about unreal artificial intelligence in diabetic retinopathy and in ocular pathologies
title_short Everything real about unreal artificial intelligence in diabetic retinopathy and in ocular pathologies
title_sort everything real about unreal artificial intelligence in diabetic retinopathy and in ocular pathologies
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606792/
https://www.ncbi.nlm.nih.gov/pubmed/36311999
http://dx.doi.org/10.4239/wjd.v13.i10.822
work_keys_str_mv AT moryaarvindkumar everythingrealaboutunrealartificialintelligenceindiabeticretinopathyandinocularpathologies
AT jantisiddharams everythingrealaboutunrealartificialintelligenceindiabeticretinopathyandinocularpathologies
AT sisodiyapriya everythingrealaboutunrealartificialintelligenceindiabeticretinopathyandinocularpathologies
AT tejaswiniantervedi everythingrealaboutunrealartificialintelligenceindiabeticretinopathyandinocularpathologies
AT prasadrajendra everythingrealaboutunrealartificialintelligenceindiabeticretinopathyandinocularpathologies
AT malikalpanar everythingrealaboutunrealartificialintelligenceindiabeticretinopathyandinocularpathologies
AT gurnanibharat everythingrealaboutunrealartificialintelligenceindiabeticretinopathyandinocularpathologies

Ejemplares similares